Trial Profile
A double-blind, placebo controlled, parallel group study of Sativex [dronabinol/cannabidiol] in subjects with symptoms of spasticity due to multiple sclerosis
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2005
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 31 Oct 2005 New trial record.